{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:34:44Z","timestamp":1793036084102,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cpcardiol.2022.101398","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T03:51:41Z","timestamp":1663041101000},"page":"101398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Novel Therapeutic Strategies to Reduce Reperfusion Injury After Acute Myocardial Infarction"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3206-6162","authenticated-orcid":false,"given":"Andreas","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharrem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2022.101398_bib0001","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehy004","article-title":"Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial","volume":"39","author":"Scholz","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0002","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Committee FS and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0003","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0004","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0006","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Committee TPTS and investigators. Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0007","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Committee P-TS and investigators. Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0008","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0009","article-title":"Heart failure after ST-elevation myocardial infarction: beyond left ventricular adverse remodeling","author":"Del Buono","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jenca","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0011","article-title":"Heart failure-related quality-of-life impairment after myocardial infarction","author":"Wohlfahrt","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0012","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0013","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10557-016-6691-0","article-title":"Cardioprotection: Where to from here?","volume":"31","author":"Kloner","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0017","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005841","article-title":"Identification of high-risk patients after ST-segment-elevation myocardial infarction: comparison between angiographic and magnetic resonance parameters","volume":"10","author":"Durante","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006568","article-title":"Coronary Microvascular obstruction: key factor in the prognosis of ST-segment-elevation myocardial infarction","volume":"10","author":"Stiermaier","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0020","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0021","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMe0803746","article-title":"Time to take myocardial reperfusion injury seriously","volume":"359","author":"Hausenloy","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0022","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0735-1097(93)90700-B","article-title":"Does reperfusion injury exist in humans?","volume":"21","author":"Kloner","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.010091","article-title":"Event-free survival following successful percutaneous intervention in acute myocardial infarction depends on microvascular perfusion","volume":"13","author":"Xie","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0024","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2007.06.005","article-title":"Preconditioning and postconditioning: united at reperfusion","volume":"116","author":"Hausenloy","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cardiores.2003.09.025","article-title":"Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury","volume":"60","author":"Hausenloy","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","article-title":"Effect of cyclosporine on reperfusion injury in acute myocardial infarction","volume":"359","author":"Piot","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0027","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1161\/01.CIR.0000016602.96363.36","article-title":"Fundamentals of reperfusion injury for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0028","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00395-009-0004-8","article-title":"The mitochondrial permeability transition pore and ischemia-reperfusion injury","volume":"104","author":"Baines","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0029","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(03)00533-9","article-title":"Mitochondrial permeability transition pore opening during myocardial reperfusion\u2013a target for cardioprotection","volume":"61","author":"Halestrap","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ahj.2012.12.008","volume":"165","author":"Chakrabarti","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.001644","article-title":"Reduction of ischemia\/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide","volume":"1","author":"Kloner","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0032","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/eurheartj\/ehv597","article-title":"EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention","volume":"37","author":"Gibson","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0033","article-title":"Therapeutic hypothermia following cardiac arrest After the TTM2 trial - more questions raised than answered","author":"Schafer","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0034","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jcin.2018.06.022","article-title":"Mortality in patients with out-of-hospital cardiac arrest undergoing a standardised protocol including therapeutic hypothermia and routine coronary angiography - experience from the HAnnover COoling REgistry (HACORE)","volume":"11","author":"Akin","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa003289","article-title":"Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia","volume":"346","author":"Bernard","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0036","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa012689","article-title":"Hypothermia after cardiac arrest study G. mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0037","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa1906661","article-title":"Targeted temperature management for cardiac arrest with nonshockable rhythm","volume":"381","author":"Lascarrou","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0038","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJV8I12A217","article-title":"A pooled analysis of the effect of endovascular cooling on infarct size in patients with ST-elevation myocardial infarction","volume":"8","author":"Erlinge","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0039","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.4244\/EIJ-D-17-00279","article-title":"COOL AMI EU pilot trial: a multicenter, prospective, randomized controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction","volume":"13","author":"Noc","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4244\/EIJ-D-21-00348","article-title":"A multicenter, prospective, randomized controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial","volume":"17","author":"Noc","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0041","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00019501-200503000-00008","article-title":"Feasibility and safety of regional myocardial hypothermia during myocardial ischemia and infarction in pigs","volume":"16","author":"Kim","year":"2005","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0042","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jacc.2006.06.080","article-title":"Catheter-based transcoronary myocardial hypothermia attenuates arrhythmia and myocardial necrosis in pigs with acute myocardial infarction","volume":"49","author":"Otake","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0043","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/jcm11041082","article-title":"Hypothermia for cardioprotection in patients with St-elevation myocardial infarction: do not give it the cold shoulder yet!","volume":"11","author":"El Farissi","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0044","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4244\/EIJ-D-19-00471","article-title":"Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial","volume":"16","author":"El Farissi","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0045","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jcin.2021.06.009","article-title":"Safety of selective intracoronary hypothermia during primary percutaneous coronary intervention in patients with anterior STEMI","volume":"14","author":"El Farissi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0046","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjcard.2016.11.037","article-title":"Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock","volume":"119","author":"Basir","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/joic.12080","article-title":"The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry","volume":"27","author":"O'Neill","year":"2014","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00074","article-title":"Influence of timing and predicted risk on mortality in Impella-treated infarct-related cardiogenic shock patients","author":"Sch\u00e4fer","year":"2020","journal-title":"Frontiers in Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0049","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00392-018-1230-6","article-title":"Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella(R) pump: results from the German Impella(R) registry","volume":"107","author":"Baumann","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0051","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2019.05.044","article-title":"Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock - a European experienced users working group opinion","volume":"291","author":"Sch\u00e4fer","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0052","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.121.058229","article-title":"Percutaneous transvalvular microaxial flow pump support in Cardiology","volume":"145","author":"L\u00fcsebrink","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0053","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2018.05.034","article-title":"Left ventricular unloading before reperfusion promotes functional recovery after myocardial infarction","volume":"72","author":"Esposito","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0054","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0735-1097(03)00084-6","article-title":"Left ventricular support by catheter-mounted axial flow pump reduces infarct size","volume":"41","author":"Meyns","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0055","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004397","article-title":"Left ventricular mechanical unloading by total support of Impella in myocardial infarction reduces infarct size, preserves left ventricular function, and prevents subsequent heart failure in dogs","volume":"11","author":"Saku","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152911","article-title":"Total mechanical unloading minimizes metabolic demand of left ventricle and dramatically reduces infarct size in myocardial infarction","volume":"11","author":"Saku","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0057","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005870","article-title":"Effects of Impella on coronary perfusion in patients with critical coronary artery stenosis","volume":"11","author":"Alqarqaz","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0058","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.118.038269","article-title":"Unloading the left ventricle before reperfusion in patients with anterior ST-segment elevation myocardial infarction: a pilot study using the Impella CP","volume":"139","author":"Kapur","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0059","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.2001.280.3.H1361","article-title":"Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemia","volume":"280","author":"Ido","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.carrev.2022.07.007","article-title":"Pressure-controlled intermittent coronary sinus occlusion: A novel approach to improve microvascular flow and reduce infarct size in STEMI","author":"Gibson","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0061","article-title":"Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study","volume":"28","author":"Egred","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0062","first-page":"329","article-title":"Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI","volume":"99","author":"Scarsini","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.630430","article-title":"C-reactive protein triggers cell death in ischemic cells","volume":"12","author":"Sheriff","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0064","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.95.1.97","article-title":"C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction","volume":"95","author":"Lagrand","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0065","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.5114\/aoms.2017.69327","article-title":"C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty","volume":"13","author":"Stumpf","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0066","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jca.21344","article-title":"Selective apheresis of C-reactive protein: a new therapeutic option in myocardial infarction?","volume":"30","author":"Sheriff","year":"2015","journal-title":"J Clin Apher"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.591714","article-title":"C-reactive protein apheresis as anti-inflammatory therapy in acute myocardial infarction: results of the CAMI-1 study","volume":"8","author":"Ries","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0068","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/01.RES.15.6.497","article-title":"Reduction by hyperbaric oxygenation of the mortality from ventricular fibrillation following coronary artery ligation","volume":"15","author":"Chardack","year":"1964","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0069","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.RES.18.1.89","article-title":"Effects of hyperbaric oxygenation on coronary artery occlusion in pigs","volume":"18","author":"Peter","year":"1966","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0140-6736(66)92258-6","article-title":"Haemodynamic and metabolic effects of hyperbaric oxygen in myocardial infarction","volume":"2","author":"Cameron","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0071","first-page":"751","article-title":"A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction","volume":"42","author":"Thurston","year":"1973","journal-title":"Q J Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0072","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00129784-200303040-00004","article-title":"Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction","volume":"3","author":"Bartorelli","year":"2003","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0073","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacbts.2021.07.011","article-title":"Update on cardioprotective strategies for STEMI: focus on supersaturated oxygen delivery","volume":"6","author":"Kloner","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0074","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/jcm11061509","article-title":"Intracoronary application of super-saturated oxygen to reduce infarct size following myocardial infarction","volume":"11","author":"Sch\u00e4fer","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2007.01.099","article-title":"Acute myocardial infarction with hyperoxemic therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention","volume":"50","author":"O'Neill","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0076","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCINTERVENTIONS.108.840066","article-title":"Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction","volume":"2","author":"Stone","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0077","first-page":"882","article-title":"Evaluation of intracoronary hyperoxemic oxygen therapy in acute anterior myocardial infarction: the IC-HOT study","volume":"93","author":"David","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2022.101398_bib0078","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1160\/TH16-07-0569","article-title":"Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction","volume":"117","author":"Flierl","year":"2017","journal-title":"Thromb Haemost"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062200295X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014628062200295X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:04:30Z","timestamp":1758938670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014628062200295X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S014628062200295X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101398","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Therapeutic Strategies to Reduce Reperfusion Injury After Acute Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101398"}}